AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures
Authors: Muller, L Provenzani, C Pawelec, G
Citation: L. Muller et al., Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures, J IMMUNOTH, 24(6), 2001, pp. 482-492
MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors
Authors: Pawelec, G Muller, L Wagner, W
Citation: G. Pawelec et al., MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors, TRENDS IMMU, 22(8), 2001, pp. 422-423
Is HLA-DR4 or the HLA-DRB10402 allele associated with decreased risk for CML?
Authors: Pawelec, G Wagner, W
Citation: G. Pawelec et W. Wagner, Is HLA-DR4 or the HLA-DRB10402 allele associated with decreased risk for CML?, LEUKEMIA, 15(1), 2001, pp. 192-193
The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+T lymphocytes to recognize melanoma cells
Authors: Heinzel, S Rea, D Offringa, R Pawelec, G
Citation: S. Heinzel et al., The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+T lymphocytes to recognize melanoma cells, CANCER IMMU, 49(12), 2001, pp. 671-678
The SENIEUR protocol after 16 years
Authors: Pawelec, G Ferguson, FG Wikby, A
Citation: G. Pawelec et al., The SENIEUR protocol after 16 years, MECH AGE D, 122(2), 2001, pp. 132-134
Altered T cell signalling in ageing
Authors: Pawelec, G Hirokawa, K Fulop, T
Citation: G. Pawelec et al., Altered T cell signalling in ageing, MECH AGE D, 122(14), 2001, pp. 1613-1637
Age-related accumulation of oxidative DNA damage and alterations in levelsof p16(INK4a/CDKN2a), p21(WAF1/CIP1/SDI1) and p27(KIP1) in human CD4+T cell clones in vitro
Authors: Hyland, P Barnett, C Pawelec, G Barnett, Y
Citation: P. Hyland et al., Age-related accumulation of oxidative DNA damage and alterations in levelsof p16(INK4a/CDKN2a), p21(WAF1/CIP1/SDI1) and p27(KIP1) in human CD4+T cell clones in vitro, MECH AGE D, 122(11), 2001, pp. 1151-1167
Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells
Authors: Muller, L Provenzani, C Faul, C Pawelec, G
Citation: L. Muller et al., Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells, BR J HAEM, 112(3), 2001, pp. 740-748
Escape mechanisms in tumour immunity
Authors: Pawelec, G
Citation: G. Pawelec, Escape mechanisms in tumour immunity, IMMUNOL MED, 30, 2001, pp. 219-247
Working together for robust immune responses in the elderly
Authors: Pawelec, G
Citation: G. Pawelec, Working together for robust immune responses in the elderly, NAT IMMUNOL, 1(2), 2000, pp. 91-91
Longevity in vitro of human CD4+T helper cell clones derived from young donors and elderly donors, or from progenitor cells: age-associated differences in cell surface molecule expression and cytokine secretion
Authors: Pawelec, G Mariani, E Bradley, B Solana, R
Citation: G. Pawelec et al., Longevity in vitro of human CD4+T helper cell clones derived from young donors and elderly donors, or from progenitor cells: age-associated differences in cell surface molecule expression and cytokine secretion, BIOGERONTOL, 1(3), 2000, pp. 247-254
ImAginE: Immunology and aging in Europe - A thematic network of the EU 5thFramework Program
Authors: Pawelec, G
Citation: G. Pawelec, ImAginE: Immunology and aging in Europe - A thematic network of the EU 5thFramework Program, IMMUNOLOGIS, 8(3), 2000, pp. 88-88
Telomeres and telomerase
Authors: Pawelec, G Effros, RB
Citation: G. Pawelec et Rb. Effros, Telomeres and telomerase, J ANTI-AG M, 3(4), 2000, pp. 361-363
ImAginE: Immunology and Ageing in Europe - A Thematic Network of the EU 5th Framework Program
Authors: Pawelec, G
Citation: G. Pawelec, ImAginE: Immunology and Ageing in Europe - A Thematic Network of the EU 5th Framework Program, EXP GERONT, 35(8), 2000, pp. 1107-1108
New methods to approach immunotherapy of cancer and strategies of tumours to avoid elimination - Conference report, on behalf of EUCAPS
Authors: Pawelec, G
Citation: G. Pawelec, New methods to approach immunotherapy of cancer and strategies of tumours to avoid elimination - Conference report, on behalf of EUCAPS, CANCER IMMU, 49(4-5), 2000, pp. 276-280
In vitro senescence models for human T lymphocytes
Authors: Pawelec, G Adibzadeh, M Rehbein, A Hahnel, K Wagner, W Engel, A
Citation: G. Pawelec et al., In vitro senescence models for human T lymphocytes, VACCINE, 18(16), 2000, pp. 1666-1674
A multidisciplinary approach to immunity and ageing: ImAginEering
Authors: Pawelec, G
Citation: G. Pawelec, A multidisciplinary approach to immunity and ageing: ImAginEering, MECH AGE D, 121(1-3), 2000, pp. 1-4
Hypothesis: loss of telomerase inducibility and subsequent replicative senescence in cultured human T cells is a result of altered costimulation
Authors: Pawelec, G
Citation: G. Pawelec, Hypothesis: loss of telomerase inducibility and subsequent replicative senescence in cultured human T cells is a result of altered costimulation, MECH AGE D, 121(1-3), 2000, pp. 181-185
Defensins are dominant HLA-DR-associated self-peptides from CD34(-) peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia)
Authors: Halder, TM Bluggel, M Heinzel, S Pawelec, G Meyer, HE Kalbacher, H
Citation: Tm. Halder et al., Defensins are dominant HLA-DR-associated self-peptides from CD34(-) peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia), BLOOD, 95(9), 2000, pp. 2890-2896
Human T-Cell clones
Authors: Pawelec, G
Citation: G. Pawelec, Human T-Cell clones, METH MOL M, 38, 2000, pp. 53-61
Identification of differentially expressed genes in young and senescent T cells
Authors: Engel, A Adibzadeh, M Pawelec, G
Citation: A. Engel et al., Identification of differentially expressed genes in young and senescent T cells, METH MOL M, 38, 2000, pp. 97-115
Telomere-dependent senescence
Authors: Kipling, D Wynford-Thomas, D Jones, CJ Akbar, A Aspinall, R Bacchetti, S Blasco, MA Broccoli, D DePinho, RA Edwards, DR Effros, RB Harley, CB Lansdorp, PM Linskens, MHK Prowse, KR Newbold, RF Olovnikov, AM Parkinson, EK Pawelec, G Ponten, J Shall, S Zijlmans, M Faragher, RGA
Citation: D. Kipling et al., Telomere-dependent senescence, NAT BIOTECH, 17(4), 1999, pp. 313-313
Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes
Authors: Potestio, M Pawelec, G Di Lorenzo, G Candore, G D'Anna, C Gervasi, F Lio, D Tranchida, G Caruso, C Romano, GC
Citation: M. Potestio et al., Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes, EXP GERONT, 34(5), 1999, pp. 659-673
T cell immunosenescence in vitro and in vivo
Authors: Pawelec, G Wagner, W Adibzadeh, M Engel, A
Citation: G. Pawelec et al., T cell immunosenescence in vitro and in vivo, EXP GERONT, 34(3), 1999, pp. 419-429
Finite lifespans of T cell clones derived from CD34(+) human haematopoietic stem cells in vitro
Authors: Pawelec, G Muller, R Rehbein, A Hahnel, K Ziegler, BL
Citation: G. Pawelec et al., Finite lifespans of T cell clones derived from CD34(+) human haematopoietic stem cells in vitro, EXP GERONT, 34(1), 1999, pp. 69-77
Risultati: 1-25 | 26-31